We are live on ! Find out more
OXFD

Oxford Immunotec Global PLC Ordinary Shares
OXFD

Delisted

OXFD was delisted on the 5th of March, 2021.

Back to rankings

42 hedge funds and large institutions have $181M invested in Oxford Immunotec Global PLC Ordinary Shares in 2013 Q4 according to their latest regulatory filings, with 42 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
42
Holders Change
+42
Holders Change %
–
% of All Funds
1.22%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.06%
New
42
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
RG
Redmile Group
California
+$16.7M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$15.1M
3
Invesco
Invesco
Georgia
+$9.73M
4
LPLP
Lansdowne Partners Limited Partnership
United Kingdom
+$9.24M
5
Alyeska Investment Group
Alyeska Investment Group
Illinois
+$8.15M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
NIP
26
Nicholas Investment Partners
California
$546K +$498K +28,170 New
Bank of New York Mellon
27
Bank of New York Mellon
New York
$389K +$356K +20,118 New
TCIM
28
TIAA CREF Investment Management
New York
$310K +$283K +15,980 New
California State Teachers Retirement System (CalSTRS)
29
California State Teachers Retirement System (CalSTRS)
California
$217K +$198K +11,200 New
TA
30
Teachers Advisors
New York
$118K +$108K +6,100 New
California Public Employees Retirement System
31
California Public Employees Retirement System
California
$107K +$99.8K +5,644 New
NFA
32
Nationwide Fund Advisors
Ohio
$92K +$84.3K +4,767 New
AIG
33
American International Group
New York
$79.3K +$72.4K +4,091 New
Citigroup
34
Citigroup
New York
$59K +$53.4K +3,019 New
SO
35
STRS Ohio
Ohio
$48K +$44.2K +2,500 New
MAA
36
Managed Account Advisors
New Jersey
$37K +$33.8K +1,910 New
Bank of America
37
Bank of America
North Carolina
$4K +$3.54K +200 New
BlackRock
38
BlackRock
New York
$3K +$2.67K +151 New
U
39
UBS
Switzerland
$2K +$1.49K +84 New
Barclays
40
Barclays
United Kingdom
$2K +$1.75K +99 New
BNP Paribas Financial Markets
41
BNP Paribas Financial Markets
France
$1.47K +$1.34K +76 New
Morgan Stanley
42
Morgan Stanley
New York
– +$159 +9 New
1
2

OXFD Hedge Fund Activity: Q4 2013 in Review

42 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in Oxford Immunotec Global PLC Ordinary Shares (OXFD) for Q4 2013, worth a combined $181M.

Buyers outnumbered sellers: 42 funds opened new OXFD positions and 0 closed out — a net gain of 42 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Redmile Group, opening a new position worth an estimated $16.7M.

  • 42 institutional investors held Oxford Immunotec Global PLC Ordinary Shares (OXFD) as of Q4 2013, up from 0 in Q3 2013.
  • Funds reported $181M of Oxford Immunotec Global PLC Ordinary Shares stock for Q4 2013.
  • 42 funds opened new Oxford Immunotec Global PLC Ordinary Shares positions in Q4 2013 and 0 closed out, a net change of +42 holders.
  • The largest Oxford Immunotec Global PLC Ordinary Shares buyer in Q4 2013 was Redmile Group, an estimated $16.7M added.

Based on aggregated 13F filings for Q4 2013.